Status:
UNKNOWN
Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation
Lead Sponsor:
Seoul National University Hospital
Conditions:
Stable Angina
Eligibility:
All Genders
30-80 years
Phase:
PHASE4
Brief Summary
Treatments for stable angina includes drug therapy such as calcium-channel blocker, beta blocker, and ACEI/ARB. To obtain good prognosis in patients with coronary artery disease,preventing or correcti...
Eligibility Criteria
Inclusion
- Stable angina patients whose coronary lesions is confirmed by angiography or receives PCI
- Unstable Angina/NSTEMI patients who completed PCI for main lesions
- Either systolic \> 130mmHg or diastolic \> 80mmHg, or patients with anti-hypertensive drugs
Exclusion
- STEMI patients within one month
- Variant Angina
- Liver function abnormality or renal failure
- History of Hypersensitivity to testing drugs
- Severe heart failure(NYHA class\>3) or uncorrectable hematologic disease
- Woman possible to be pregnant
- Uncontrolled diabetes
- Expected life span \< one year
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01162902
Start Date
September 1 2013
End Date
December 1 2015
Last Update
December 17 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea